PERISCOPE CAPITAL INC. - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 2 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
PERISCOPE CAPITAL INC. ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$4,064
-88.0%
362,8110.0%0.00%
-100.0%
Q3 2022$34,000
+240.0%
362,811
+190.5%
0.00%–
Q2 2022$10,000
-60.0%
124,9000.0%0.00%
-100.0%
Q1 2022$25,000
-62.7%
124,9000.0%0.00%
-50.0%
Q4 2021$67,000–124,900–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 9,800$108,0540.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders